AnnoGen is a company headquartered in France.
AnnoGen develops bespoke gene expression engineering technologies, including proprietary platforms for designing and optimizing gene promoters and transgene expression sites across various tissues and organisms, supporting applications in cell and gene therapy manufacturing and crop engineering.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.